CALUMET SPECIALTY PRODS PTNR's ticker is CLMT and the CUSIP is 131476103. A total of 67 filers reported holding CALUMET SPECIALTY PRODS PTNR in Q2 2024. The put-call ratio across all filers is 1.07 and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $69,416 | +8.0% | 4,325,000 | 0.0% | 27.70% | +21.9% |
| Q1 2024 | $64,270 | -16.8% | 4,325,000 | 0.0% | 22.73% | -23.1% |
| Q4 2023 | $77,288 | -6.4% | 4,325,000 | 0.0% | 29.54% | -6.3% |
| Q3 2023 | $82,608 | +20.4% | 4,325,000 | 0.0% | 31.54% | +15.5% |
| Q2 2023 | $68,595 | -8.7% | 4,325,000 | 0.0% | 27.30% | -7.6% |
| Q1 2023 | $75,169 | +3.0% | 4,325,000 | 0.0% | 29.54% | +7.1% |
| Q4 2022 | $73,006 | -99.9% | 4,325,000 | -2.6% | 27.58% | +15.2% |
| Q3 2022 | $56,876,000 | +26.6% | 4,440,000 | +2.7% | 23.94% | +26.8% |
| Q2 2022 | $44,937,000 | -24.8% | 4,325,000 | -1.5% | 18.87% | -0.9% |
| Q1 2022 | $59,782,000 | +2.4% | 4,392,500 | +11.0% | 19.04% | -4.0% |
| Q4 2021 | $58,406,000 | – | 3,956,727 | – | 19.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wasserstein Debt Opportunities Management, L.P. | 6,891,314 | $110,605,590 | 100.00% |
| Knott David M Jr | 4,325,000 | $69,416 | 27.70% |
| Adams Asset Advisors, LLC | 5,251,160 | $84,281,118 | 10.99% |
| GRIZZLYROCK CAPITAL, LLC | 537,602 | $8,628,512 | 7.16% |
| Barnett & Company, Inc. | 281,415 | $4,516,716 | 3.24% |
| Bienville Capital Management, LLC | 341,102 | $5,474,687 | 1.31% |
| EPACRIA CAPITAL PARTNERS, LLC | 76,037 | $1,220,394 | 0.90% |
| Alta Fundamental Advisers LLC | 75,287 | $1,208,356 | 0.38% |
| FIFTH LANE CAPITAL, LP | 15,000 | $240,750 | 0.35% |
| Gimbal Financial | 27,045 | $458,954 | 0.34% |